Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: Role of TLR4 and TLR2

Neuropharmacology

Volumn 89, Issue , 2015, Pages 352-359

  Pascual, María ^a   Baliño, Pablo ^b   Aragón, Carlos M G ^b   Guerri, Consuelo ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITAT JAUME I   (Spain)

Author keywords

Anxiety; Cytokines; Ethanol; Neuroinflammation; TLR4; Withdrawal

Indexed keywords

ALCOHOL; CHEMOKINE; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CENTRAL DEPRESSANT AGENT; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; INNATE IMMUNITY; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; RECEPTOR UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MAZE TEST; METABOLISM; VISUAL ADAPTATION;

ADAPTATION, OCULAR; ANIMALS; ANXIETY; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ETHANOL; GENE EXPRESSION REGULATION; MALE; MAZE LEARNING; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84908701389     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.10.014     Document Type: Article

References (62)

1. Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A.M., Sanchez-Vera, I., Guerri, C., 2010. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 30, 8285-8295.
2. Alfonso-Loeches, S., Pascual, M., Gomez-Pinedo, U., Pascual-Lucas, M., Renau-Piqueras, J., Guerri, C., 2012. Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia 60, 948-964.
3. Appelberg, R., 1992. Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J. Leukoc. Biol. 52, 303-306.
4. Araos, P., Pedraz, M., Serrano, A., Lucena, M., Barrios, V., Garcia-Marchena, N., Campos-Cloute, R., Ruiz, J.J., Romero, P., Suarez, J., Baixeras, E., de la Torre, R., Montesinos, J., Guerri, C., Rodriguez-Arias, M., Minarro, J., Martinez-Riera, R., Torrens, M., Chowen, J.A., Argente, J., Mason, B.J., Pavon, F.J., Rodriguez de Fonseca, F., 2014. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addict. Biol. (in press).
5. Bala, S., Marcos, M., Gattu, A., Catalano, D., Szabo, G., 2014. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS One 9, e96864.
6. Beumer, W., Gibney, S.M., Drexhage, R.C., Pont-Lezica, L., Doorduin, J., Klein, H.C., Steiner, J., Connor, T.J., Harkin, A., Versnel, M.A., Drexhage, H.A., 2012. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 92, 959-975.
7. Bilkei-Gorzo, A., Gyertyan, I., Levay, G., 1998. mCPP-induced anxiety in the lightdark box in ratsea new method for screening anxiolytic activity. Psychopharmacology (Berl) 136, 291-298.
8. Blanco, A.M., Valles, S.L., Pascual, M., Guerri, C., 2005. Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 175, 6893-6899.
9. Bonaccorso, S., Puzella, A., Marino, V., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Levrero, M., Egyed, B., Bosmans, E., Meltzer, H.Y., Maes, M., 2001. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res. 105, 45-55.
10. Bourin, M., Hascoet, M., 2003. The mouse light/dark box test. Eur. J. Pharmacol. 463, 55-65.
11. Breese, G.R., Knapp, D.J., Overstreet, D.H., Navarro, M., Wills, T.A., Angel, R.A., 2008. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 33, 867-876.
12. Calsavara, A.C., Rodrigues, D.H., Miranda, A.S., Costa, P.A., Lima, C.X., Vilela, M.C., Rachid, M.A., Teixeira, A.L., 2013. Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis. Neurotox. Res. 24, 103-108.
13. Campbell, S.J., Perry, V.H., Pitossi, F.J., Butchart, A.G., Chertoff, M., Waters, S., Dempster, R., Anthony, D.C., 2005. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am. J. Pathol. 166, 1487-1497.
14. Cotter, R., Williams, C., Ryan, L., Erichsen, D., Lopez, A., Peng, H., Zheng, J., 2002. Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 8, 585-598.
15. Cragnolini, A.B., Schioth, H.B., Scimonelli, T.N., 2006. Anxiety-like behavior induced by IL-1beta is modulated by alpha-MSH through central melanocortin-4 receptors. Peptides 27, 1451-1456.
16. Crews, F.T., Bechara, R., Brown, L.A., Guidot, D.M., Mandrekar, P., Oak, S., Qin, L., Szabo, G., Wheeler, M., Zou, J., 2006. Cytokines and alcohol. Alcohol. Clin. Exp. Res. 30, 720-730.
17. Chen, G., Cuzon Carlson, V.C., Wang, J., Beck, A., Heinz, A., Ron, D., Lovinger, D.M., Buck, K.J., 2011. Striatal involvement in human alcoholism and alcohol consumption, and withdrawal in animal models. Alcohol Clin. Exp. Res. 35, 1739-1748.
18. Chester, J.A., Blose, A.M., Froehlich, J.C., 2003. Further evidence of an inverse genetic relationship between innate differences in alcohol preference and alcohol withdrawal magnitude in multiple selectively bred rat lines. Alcohol Clin. Exp. Res. 27, 377-387.
19. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56.
20. Driessen, M., Meier, S., Hill, A., Wetterling, T., Lange, W., Junghanns, K., 2001. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol. 36, 249-255.
21. Fernandez-Lizarbe, S., Montesinos, J., Guerri, C., 2013. Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells. J. Neurochem. 126, 261-273.
22. Fernandez-Lizarbe, S., Pascual, M., Guerri, C., 2009. Critical role of TLR4 response in the activation of microglia induced by ethanol. J. Immunol. 183, 4733-4744.
23. Frank, M.G., Watkins, L.R., Maier, S.F., 2011. Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stressinduced vulnerability to drugs of abuse. Brain Behav. Immun. 25 (Suppl. 1), S21-S28.
24. Franklin, R.J., Ffrench-Constant, C., 2008. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839-855.
25. Freeman, K., Brureau, A., Vadigepalli, R., Staehle, M.M., Brureau, M.M., Gonye, G.E., Hoek, J.B., Hooper, D.C., Schwaber, J.S., 2012. Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei. J. Neuroinflammation 9, 97.
26. Friedman, H., Eisenstein, T.K., 2004. Neurological basis of drug dependence and its effects on the immune system. J. Neuroimmunol. 147, 106-108.
27. Glabinski, A.R., Balasingam, V., Tani, M., Kunkel, S.L., Strieter, R.M., Yong, V.W., Ransohoff, R.M., 1996. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156, 4363-4368.
28. He, J., Crews, F.T., 2008. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 210, 349-358.
29. Hergenroeder, G.W., Moore, A.N., McCoy Jr., J.P., Samsel, L., Ward 3rd, N.H., Clifton, G.L., Dash, P.K., 2010. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J. Neuroinflammation 7, 19.
30. Hughes, P.M., Botham, M.S., Frentzel, S., Mir, A., Perry, V.H., 2002. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37, 314-327.
31. Iwasaki, A., Medzhitov, R., 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995.
32. Kane, C.J., Phelan, K.D., Douglas, J.C., Wagoner, G., Johnson, J.W., Xu, J., Drew, P.D., 2013. Effects of ethanol on immune response in the brain: region-specific changes in aged mice. J. Neuroinflammation 10, 66.
33. Keogh, B., Parker, A.E., 2011. Toll-like receptors as targets for immune disorders. Trends Pharmacol. Sci. 32, 435-442.
34. Kliethermes, C.L., 2005. Anxiety-like behaviors following chronic ethanol exposure. Neurosci. Biobehav. Rev. 28, 837-850.
35. Kliethermes, C.L., Cronise, K., Crabbe, J.C., 2004. Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation. Alcohol Clin. Exp. Res. 28, 1012-1019.
36. Kliethermes, C.L., Finn, D.A., Crabbe, J.C., 2003. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology (Berl) 169, 190-197.
37. Koob, G.F., 2003. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 27, 232-243.
38. Koob, G.F., Volkow, N.D., 2010. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238.
39. Kosten, T.R., O'Connor, P.G., 2003. Management of drug and alcohol withdrawal. N. Engl. J. Med. 348, 1786-1795.
40. Lacosta, S., Merali, Z., Anisman, H., 1999. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 818, 291-303.
41. Lopez, M.F., Becker, H.C., 2005. Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice. Psychopharmacology (Berl) 181, 688-696.
42. Mayfield, J., Ferguson, L., Harris, R.A., 2013. Neuroimmune signaling: a key component of alcohol abuse. Curr. Opin. Neurobiol. 23, 513-520.
43. Mayo-Smith, M.F., 1997. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278, 144-151.
44. McClain, C.J., Barve, S., Deaciuc, I., Kugelmas, M., Hill, D., 1999. Cytokines in alcoholic liver disease. Semin. Liver Dis. 19, 205-219.
45. McClain, C.J., Cohen, D.A., 1989. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9, 349-351.
46. Okun, E., Griffioen, K.J., Lathia, J.D., Tang, S.C., Mattson, M.P., Arumugam, T.V., 2009. Toll-like receptors in neurodegeneration. Brain Res. Rev. 59, 278-292.
47. Pascual, M., Balino, P., Alfonso-Loeches, S., Aragon, C.M., Guerri, C., 2011. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav. Immun. 25 (Suppl. 1), S80-S91.
48. Qin, L., Crews, F.T., 2012. Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration. J. Neuroinfl ammation 9, 130.
49. Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., Patra, J., 2009. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373, 2223-2233.
50. Robin, L.A., Martin, P.P., 2010. Neural systems underlying approach and avoidance in anxiety disorders. Dialogues Clin. Neurosci. 12, 517-531.
51. Schrott, L.M., Crnic, L.S., 1996. Increased anxiety behaviors in autoimmune mice. Behav. Neurosci. 110, 492-502.
52. Smith, R.J., Aston-Jones, G., 2008. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct. 213, 43-61.
53. Song, F., Poljak, A., Smythe, G.A., Sachdev, P., 2009. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res. Rev. 61, 69-80.
54. Staiger, P.K., Thomas, A.C., Ricciardelli, L.A., McCabe, M.P., 2011. Identifying depression and anxiety disorders in people presenting for substance use treatment. Med. J. Aust. 195, S60-S63.
55. Valles, S.L., Blanco, A.M., Pascual, M., Guerri, C., 2004. Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes. Brain Pathol. 14, 365-371.
56. Weber, M.D., Frank, M.G., Sobesky, J.L., Watkins, L.R., Maier, S.F., 2013. Blocking tolllike receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge. Brain Behav. Immun. 32, 112-121.
57. Whitman, B.A., Knapp, D.J., Werner, D.F., Crews, F.T., Breese, G.R., 2013. The cytokine mRNA increase induced by withdrawal from chronic ethanol in the sterile environment of brain is mediated by CRF and HMGB1 release. Alcohol. Clin. Exp. Res. 37, 2086-2097.
58. WHO, 2014. Global Status Report on Alcohol and Health. WHO Press, Geneva.
59. Wolpe, S.D., Davatelis, G., Sherry, B., Beutler, B., Hesse, D.G., Nguyen, H.T., Moldawer, L.L., Nathan, C.F., Lowry, S.F., Cerami, A., 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167, 570-581.
60. Yang, H., Spence, J.S., Devous Sr., M.D., Briggs, R.W., Goyal, A., Xiao, H., Yadav, H., Adinoff, B., 2012. Striatal-limbic activation is associated with intensity of anticipatory anxiety. Psychiatry Res. 204, 123-131.
61. Yirmiya, R., Goshen, I., 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25, 181-213.
62. Zlotnik, A., Yoshie, O., 2000. Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.